TABLE OF CONTENTS - Tech Transfer Centraltechtransfercentral.com/wp-content/uploads/2011/05/Manufacturing... · Case study 4: Elite Pharmaceuticals ... Eli Lilly Endo Pharmaceuticals.
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
This brochure is published by Wildwood Ventures Ltd.
Chapter 2 – Trends in manufacturing and supply dealmaking
2.1. Introduction 2.2. Difference between manufacturing and supply deals 2.3. Trends in manufacturing deals since 2009 2.4. Trends in supply deals since 2009
2.4.1. When supply can be useful 2.5. Attributes of pure manufacturing and supply deals 2.6. Attributes of manufacturing and supply in multi-component deals 2.7. Reasons for including manufacturing and supply options in a multicomponent deal 2.8. The future of manufacture and supply as part of multicomponent deals
Chapter 3 – Overview of manufacturing and supply deal structure
3.1. Introduction 3.2. Pure versus multi-component manufacturing deals 3.3. Pure manufacturing agreement structure
3.3.1. Example manufacturing agreements 3.3.1.a. Case study 1: Amyris Brazil – Biomin Nutricao Animal Do Brasil 3.3.1.b. Case study 2: Patheon – Orexigen Therapeutics
3.4. Manufacturing rights as part of a wider alliance agreement 3.4.1. Example multicomponent manufacturing clauses 3.4.1.a. Case study 3: Agenus Bio – NewVac 3.4.1.b. Case study 4: Elite Pharmaceuticals – Hi-Tech Pharmacal
Chapter 4 – Overview of supply deal structure
4.1. Introduction 4.2. Supply agreement structure
4.2.1. Example supply agreements 4.2.1.a. Case study 5: Omthera Pharmaceuticals – Catalent Pharma solutions 4.2.1.b. Case study 6: Endo Pharmaceuticals – Noramco
4.3. Supply rights as part of a wider alliance agreement 4.3.1. Example co-marketing right clauses 4.3.1.a. Case study 7: Auxilium Pharmaceuticals – Asahi Kasei 4.3.1.b. Case study 8: Durata Therapeutics - Hospira
This brochure is published by Wildwood Ventures Ltd.
5.1. Introduction 5.2. Top manufacturing deals by value 5.3. Most active manufacturing dealmakers 5.4. Big pharma manufacturing deal activity 5.5. Big biotech manufacturing deal activity
Chapter 6 – Leading supply deals
6.1. Introduction 6.2. Top supply deals by value 6.3. Most active supply dealmakers 6.4. Bigpharma supply deal activity 6.4. Big biotech supply deal activity
Chapter 7 – Big pharma manufacturing and supply deals
7.1. Introduction 7.2. How to use manufacturing and supply deals 7.3. Bigpharma company manufacturing and supply deal profiles
Abbott Abbott Medical Optics Abbott Japan Abbott Laboratories Actavis (formerly knows as Watson) Allergan Amgen Astellas AstraZeneca Baxter International Bayer Biogen Idec Boehringer Ingelheim Bristol-Myers Squibb Celgene CSL Daiichi Sankyo Dainippon Sumitomo Eisai Eli Lilly Endo Pharmaceuticals
This brochure is published by Wildwood Ventures Ltd.
Aastrom Biosciences Abbott Laboratories ACADIA Pharmaceuticals ACS Dobfar ADMA Biologics Advance Pharmaceutical Advanced Biohealing Agenus Bio Albany Molecular Research Alexza Pharmaceuticals Alimera Sciences Alkaloida Chemical Company Allergan Alliance Medical Products Alnylam Pharmaceuticals Alseres Pharmaceuticals Amgen Amicus Therapeutics Amol Pharmaceuticals Amylin Pharmaceuticals Amyris Biotechnologies Amyris Brazil Antigenics Applied DNA Sciences Arch Pharmalabs Arena Pharmaceuticals Ascend Laboratories ATEK Medical Aubrey Group Autoliv ASP Auxilium Pharmaceuticals Avanir Pharmaceuticals Bachem Baxter Healthcare Biocon Group Biomedical Advanced Research and Development Authority BioMimetic Therapeutics Biomin Nutricao Animal Do Brasil Biotage
This brochure is published by Wildwood Ventures Ltd.
Recent report titles from CurrentPartnering Order Form – Reports Order Form – Reports
View the accompanying appendices for:
Appendix 1 – Company A-Z manufacturing dealsAppendix 2 – By therapy area - manufacturingAppendix 3 – By stage of development at signing - manufacturingAppendix 4 – By technology type – manufacturingAppendix 5 – Company A-Z - supply dealsAppendix 6 – By therapy area - supplyAppendix 7 – By stage of development at signing - supplyAppendix 8 – By technology type – supplyAppendix 9 –Dealmaking referencesAppendix 10 – ResourcesAppendix 11 – Deal type definitionsAppendix 12 – Example supply contract document
This brochure is published by Wildwood Ventures Ltd.
Figure 1: Definition of manufacturing and supply Figure 2: Types of manufacturing agreement Figure 3: Trends in manufacturing deal announcements, 2009-2013 Figure 4: Manufacturing deals signed by phase of development, 2009-2013 Figure 5: Trends in supply deal announcements, 2009-2013 Figure 6: Supply deals signed at what phase of development, 2009-2013 Figure 7: Situations where supply deals can prove useful Figure 8: Components of the manufacturing deal structure Figure 9: Components of the supply deal structure Figure 10: Top manufacturing deals by value since 2009 Figure 11: Most active manufacturing dealmakers 2009-2013 Figure 12: Big pharma – top 50 – manufacturing deals 2009 to June 2013 Figure 13: Big pharma manufacturing deal frequency - 2009 to mid 2013 Figure 14: Big biotech – top 50 – manufacturing deals 2009 to June 2013 Figure 15: Top supply deals by value since 2009 Figure 16: Most active supply dealmakers 2009-2012 Figure 17: Bigpharma – top 50 – supply deals 2009 to 2013 Figure 18: Bigpharma supply deal frequency - 2009 to 2013 Figure 19: Big biotech – top 50 – supply deals 2009 to 2013 Figure 20: Big biotech supply deal frequency - 2009 to 2013